The Utility of Cannabidiol in the Treatment of Refractory Epilepsy. Academic Article uri icon

abstract

  • Cannabis-derived cannabinoids such as cannabidiol (CBD) have anticonvulsant properties. Recently, there has been an emerging interest in the use of CBD-enriched products for treatment of drug-resistant epilepsy. Some pilot trials of CBD have proved beneficial for refractory epilepsy, but its efficacy is yet to be confirmed by standard placebo-controlled trials. However, the mechanisms underlying the seizure protection efficacy claims of CBD remain unclear. This review briefly describes the clinical utility of CBD in the treatment of refractory epilepsy.

published proceedings

  • Clin Pharmacol Ther

altmetric score

  • 1.5

author list (cited authors)

  • Reddy, D. S.

citation count

  • 30

complete list of authors

  • Reddy, DS

publication date

  • February 2017

publisher